skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 next page
Mostrar Somente
Refinado por: assunto: Adult remover assunto: Leukopenia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000-2022: a binational cohort study
Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000-2022: a binational cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sepsis mortality among patients with haematological malignancy admitted to intensive care 2000-2022: a binational cohort study

MacPhail, Aleece ; Dendle, Claire ; Slavin, Monica ; Weinkove, Robert ; Bailey, Michael ; Pilcher, David ; McQuilten, Zoe

Critical care (London, England), 2024-05, Vol.28 (1), p.148-148 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series
Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series

Mendes-de-Almeida, Daniela P ; Bokel, Joanna Paes Barreto ; Alves, Arthur Daniel Rocha ; Vizzoni, Alexandre G ; Tavares, Isabel Cristina Ferreira ; Silva, Mayara Secco Torres ; Netto, Juliana Dos Santos Barbosa ; Grinsztejn, Beatriz Gilda Jegerhorn ; Amado Leon, Luciane Almeida

Viruses, 2023-05, Vol.15 (5), p.1124 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
3
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial

Leypoldt, Lisa B ; Besemer, Britta ; Asemissen, Anne Marie ; Hänel, Mathias ; Blau, Igor Wolfgang ; Görner, Martin ; Ko, Yon-Dschun ; Reinhardt, Hans Christian ; Staib, Peter ; Mann, Christoph ; Lutz, Raphael ; Munder, Markus ; Graeven, Ullrich ; Peceny, Rudolf ; Salwender, Hans ; Jauch, Anna ; Zago, Manola ; Benner, Axel ; Tichy, Diana ; Bokemeyer, Carsten ; Goldschmidt, Hartmut ; Weisel, Katja C

Leukemia, 2022-03, Vol.36 (3), p.885-888 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Bardia, Aditya ; Hurvitz, Sara A ; Tolaney, Sara M ; Loirat, Delphine ; Punie, Kevin ; Oliveira, Mafalda ; Brufsky, Adam ; Sardesai, Sagar D ; Kalinsky, Kevin ; Zelnak, Amelia B ; Weaver, Robert ; Traina, Tiffany ; Dalenc, Florence ; Aftimos, Philippe ; Lynce, Filipa ; Diab, Sami ; Cortés, Javier ; O’Shaughnessy, Joyce ; Diéras, Véronique ; Ferrario, Cristiano ; Schmid, Peter ; Carey, Lisa A ; Gianni, Luca ; Piccart, Martine J ; Loibl, Sibylle ; Goldenberg, David M ; Hong, Quan ; Olivo, Martin S ; Itri, Loretta M ; Rugo, Hope S

The New England journal of medicine, 2021-04, Vol.384 (16), p.1529-1541 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer

Cai, Gang ; Cao, Lu ; Kirova, Youlia M ; Feng, Yan ; Chen, Jia-Yi

Radiation oncology (London, England), 2019-07, Vol.14 (1), p.115-115, Article 115 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer
Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

Holmes, Frankie Ann ; Hellerstedt, Beth A. ; Pippen, John E. ; Vukelja, Svetislava J. ; Collea, Rufus P. ; Kocs, Darren M. ; Blum, Joanne L. ; McIntyre, Kristi J. ; Barve, Minal A. ; Brooks, Barry D. ; Osborne, Cynthia R. ; Wang, Yunfei ; Asmar, Lina ; O'Shaughnessy, Joyce

Cancer medicine (Malden, MA), 2018-06, Vol.7 (6), p.2288-2298 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
7
A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients
A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients

Chanprapaph, K ; Sawatwarakul, S ; Vachiramon, V

Lupus, 2017-10, Vol.26 (12), p.1278-1284 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

Citações Citado por
8
Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study
Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study

Zhang, Jianyuan ; Chen, Shaojun ; Li, Guisheng ; Zhang, Weihua ; Qin, Tingting ; Yin, Ping ; Huang, Haixin ; Jiang, Hongwei

Cancer chemotherapy and pharmacology, 2017-06, Vol.79 (6), p.1087-1097 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Long‐term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial
Long‐term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long‐term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial

Song, Tao ; Zhang, Xuebang ; Fang, Min ; Zhao, Ruping ; Wu, Shixiu

Cancer medicine (Malden, MA), 2016-12, Vol.5 (12), p.3371-3377 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
10
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Hortobagyi, Gabriel N ; Stemmer, Salomon M ; Burris, Howard A ; Yap, Yoon-Sim ; Sonke, Gabe S ; Paluch-Shimon, Shani ; Campone, Mario ; Blackwell, Kimberly L ; André, Fabrice ; Winer, Eric P ; Janni, Wolfgang ; Verma, Sunil ; Conte, Pierfranco ; Arteaga, Carlos L ; Cameron, David A ; Petrakova, Katarina ; Hart, Lowell L ; Villanueva, Cristian ; Chan, Arlene ; Jakobsen, Erik ; Nusch, Arnd ; Burdaeva, Olga ; Grischke, Eva-Maria ; Alba, Emilio ; Wist, Erik ; Marschner, Norbert ; Favret, Anne M ; Yardley, Denise ; Bachelot, Thomas ; Tseng, Ling-Ming ; Blau, Sibel ; Xuan, Fengjuan ; Souami, Farida ; Miller, Michelle ; Germa, Caroline ; Hirawat, Samit ; O’Shaughnessy, Joyce

The New England journal of medicine, 2016-11, Vol.375 (18), p.1738-1748 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
Resultados 1 2 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (13)
  2. Revistas revisadas por pares (12)

Data de Publicação 

De até
Refinar
  1. Antes de1989  (8)
  2. 1989Até1996  (10)
  3. 1997Até2004  (8)
  4. 2005Até2013  (11)
  5. Após 2013  (11)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Godoy, I
  2. Campana, Á
  3. Staut, L
  4. Silva, F
  5. Junqueira, V

Neste Assunto:

  1. Humans
  2. Adult
  3. Leukopenia
  4. Female
  5. Adult

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.